Standout Papers

Innate production of TH2 c... 1966 2026 1986 2006 1.5k
  1. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells (2009)
    Kazuyo Moro, Taketo Yamada et al. Nature
  2. Treatment of rheumatoid arthritis with humanized anti–interleukin‐6 receptor antibody: A multicenter, double‐blind, placebo‐controlled trial (2004)
    Norihiro Nishimoto, Kazuyuki Yoshizaki et al. Arthritis & Rheumatism
  3. New antibiotics, bleomycin A and B. (1966)
    Hitoshi Umezawa, Kazuhiko Maeda et al. PubMed
  4. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab (2007)
    Naoki Nishimoto, Jun Hashi­moto et al. Annals of the Rheumatic Diseases
  5. Translating IL-6 biology into effective treatments (2020)
    Ernest Choy, Fabrizio De Benedetti et al. Nature Reviews Rheumatology
  6. Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease‐Modifying Antirheumatic Drug Treatment (2016)
    Roy Fleischmann, Michael Schiff et al. Arthritis & Rheumatology
  7. Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy (2019)
    Mark C. Genovese, Kenneth Kalunian et al. JAMA

Immediate Impact

6 by Nobel laureates 49 from Science/Nature 188 standout
Sub-graph 1 of 15

Citing Papers

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
2021 Standout
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
2021 Standout
2 intermediate papers

Works of Tsutomu Takeuchi being referenced

Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐Naive Patients With Moderately‐to‐Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Multicenter, Multi‐Country, Randomized, Double‐Blind, Active Comparator–Controlled Trial
2020
Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review
2017
and 2 more

Author Peers

Author Last Decade Papers Cites
Tsutomu Takeuchi 12179 3318 8694 4684 1.2k 29.7k
Yoshiya Tanaka 14001 3728 9387 5090 1.1k 29.3k
Gerd R Burmester 15224 3064 8677 5224 589 27.4k
T. Huizinga 27698 3938 14454 6763 1.1k 48.2k
Peter E. Lipsky 13513 2716 22950 4478 652 45.8k
David Isenberg 27187 2718 22345 4407 950 44.7k
Yehuda Shoenfeld 22447 2225 19589 8112 1.6k 60.8k
Jörg J. Goronzy 9463 2380 20948 1635 421 39.5k
Iain B. McInnes 23614 2474 24776 10101 721 56.6k
Georg Schett 21847 2610 17536 5952 1.1k 57.5k
Hisashi Yamanaka 9241 1866 2694 2466 718 17.1k

All Works

Loading papers...

Rankless by CCL
2026